[PDF][PDF] Új, NGS alapú módszer kidolgozása a pajzsmirigy hideg göbök malignizálódásának előrejelzésére
B Kocsis-Deák - 2020 - repo.lib.semmelweis.hu
Hazánkban a pajzsmirigy betegségei a lakosság nagy hányadát érintik, ezért
népbetegségnek tekintjük. A legismertebb pajzsmirigy rendellenességek(alul-és …
népbetegségnek tekintjük. A legismertebb pajzsmirigy rendellenességek(alul-és …
Análise de marcadores moleculares como potenciais preditores de malignidade em tumores epiteliais da tireoide
SAS GASPAR - 2021 - tede2.ufma.br
Introdução: O câncer de tireoide (CT) é a neoplasia endócrina mais frequente em todo o
mundo e sua incidência vem crescendo significativamente nas últimas três décadas, sendo …
mundo e sua incidência vem crescendo significativamente nas últimas três décadas, sendo …
[引用][C] Savremena molekularno-biološka ispitivanja prognostičkih faktora papilarnog tiroidnog karcinoma i mogućnost njihove primene u kliničkoj praksi
I Đorić, J Janković… - Trendovi u …, 2021 - Beograd: Institut za molekularnu …
Poorly Differentiated Carcinoma and Anaplastic Carcinoma of the Thyroid
F Maletta, J Metovic, M Volante, M Papotti - Thyroid FNA Cytology …, 2019 - Springer
Poorly differentiated thyroid carcinoma (PDTC) is an uncommon thyroid malignancy with
biological behavior intermediate between well-differentiated (WDTC) and anaplastic thyroid …
biological behavior intermediate between well-differentiated (WDTC) and anaplastic thyroid …
Clinical significance of BRAFV600E and TERT promoter mutation in papillary thyroid microcarcinoma
J Xue, Q Liu, Y Tian, X Hou - Oncology and Translational …, 2019 - journals.lww.com
Objective The objective of this study was to analyze the correlation between BRAF V600E
and TERT promoter mutations and papillary thyroid microcarcinoma (PTMC) risk factors, and …
and TERT promoter mutations and papillary thyroid microcarcinoma (PTMC) risk factors, and …
Clinical value of BRAF V600E in thyroid carcinoma and the effect of telomerase reverse transcriptase promoter mutations
C Zhao, Z Jia - Sheng wu yi xue Gong Cheng xue za zhi= Journal of …, 2019 - europepmc.org
近年来, 由于甲状腺癌的发病率越来越高, 世界各地的学者开始更多地关注甲状腺癌,
对其发病机制, 疾病演变及转归预后都进行了探索研究. 其中基因分子领域的研究成为热点 …
对其发病机制, 疾病演变及转归预后都进行了探索研究. 其中基因分子领域的研究成为热点 …
[PDF][PDF] Characterization of the genetic profile of a consecutive series of papillary thyroid carcinomas
EO Teixeira - 2018 - repositorio-aberto.up.pt
The thyroids name arose from the Greek thyreoeidos (thyreos–shield, eidos–from), given its
shape, which is also frequently referred as a “butterfly shape”. The thyroid gland is the first …
shape, which is also frequently referred as a “butterfly shape”. The thyroid gland is the first …
The Art and Science of Thyroid Surgery in the Age of Genomics: 100 years after Theodor Kocher/Genomik Çaðýnda Tiroid Cerrahi Sanat ve Bilimi: Theodor Kocher' …
MD Seza Gulec - Molecular Imaging and Radionuclide …, 2017 - search.proquest.com
Cancer is a disorder of the genome. The thyroid cancer genome is being decoded. Recent
studies have identified a mutation or a genetic alteration in 95% of thyroid cancers. The …
studies have identified a mutation or a genetic alteration in 95% of thyroid cancers. The …
Advances in the study of genes associated with papillary thyroid carcinoma
HAO Jing, LIU Sheng - Lingnan Modern Clinics In Surgery, 2016 - lingnanwaike.com
Thyroid carcinoma is the most common malignant tumor of endocrine organs. Papillary
thyroid carcinoma accounts for approximately 90% of thyroid cancers. While most tumors …
thyroid carcinoma accounts for approximately 90% of thyroid cancers. While most tumors …
[引用][C] Papiller Tiroid Kanseri Hastalarında Braf, Nras, Tert Promoter Mutasyon Sıklığı ve Mutasyonların Klinikopatolojik Özellikler ve Uzak Metastaz ile İlişkisinin …
E Yılmaz - 2022 - Tıp Fakültesi